Opus Genetics – the next BEST thing!
The latest research news from Retina UK.
Search results
The latest research news from Retina UK.
Introducing Splice Bio, a genetic medicines company with some exciting developments for Stargardt’s patients.
The Spring 2023 edition of the Retina UK newsletter, Look Forward, which includes articles about our upcoming events, research updates and more.
Cycle with #TeamRetinaUK at Ride Reigate 2026 and get behind our ground-breaking work.
Hajrah Sarkar is a PhD student whose project is funded by Retina UK.
Raise money to help support people affected by inherited sight loss to lead better lives today and accelerate the search for treatments for the future.
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Ocugen’s gene therapy candidate, OCU410ST, is an experimental treatment designed to slow vision loss in Stargardt disease, an inherited retinal disease (IRD) with no approved therapies currently.
Inside: Our intrepid Sahara Trek #TeamRetinaUK tell us about their incredible experience. 2026 is now fully underway and we are excited to tell you about our plans. Could you take part in a challenge event or volunteer to do a bucket collection in London for Retina UK?
Our monthly e-Newsletter featuring the latest updates from Retina UK.